https://cdr.digitellinc.com/p/cf/innovations-in-dermatological-sciences-conference-posters-10
https://cdr.digitellinc.com/p/cf/innovations-in-dermatological-sciences-conference-sessions-14
https://cdr.digitellinc.com/p/s/poster-session-18
https://cdr.digitellinc.com/p/s/rutgers-and-cdr-welcome-20
https://cdr.digitellinc.com/p/s/plenary-session-new-concepts-in-skin-care-25
https://cdr.digitellinc.com/p/s/topical-delivery-the-importance-of-the-right-formulation-in-topical-drug-development-30
https://cdr.digitellinc.com/p/s/the-healthy-skin-microbiome-stability-and-resilience-35
https://cdr.digitellinc.com/p/s/virtual-vendor-showcase-40
https://cdr.digitellinc.com/p/s/hyvia-r-a-vitamin-f-enriched-chia-seed-extract-for-skin-protection-45
https://cdr.digitellinc.com/p/s/a-novel-aiml-driven-in-silico-simulation-of-the-opioid-drug-transdermal-absorption-in-normal-skin-and-cutaneous-lesions-50
https://cdr.digitellinc.com/p/s/potential-uses-of-botanicals-in-personal-care-products-challenges-and-opportunities-55
https://cdr.digitellinc.com/p/s/poster-session-60
https://cdr.digitellinc.com/p/s/plenary-session-impact-of-aging-on-skin-function-70
https://cdr.digitellinc.com/p/s/lipid-metabolic-events-underlying-formation-of-the-corneocyte-lipid-envelope-75
https://cdr.digitellinc.com/p/s/barrier-mimicry-in-the-development-of-topical-skin-health-formulations-80
https://cdr.digitellinc.com/p/s/management-of-hair-loss-by-normalizing-bcl2-levels-in-the-scalp-85
https://cdr.digitellinc.com/p/s/virtual-vendor-showcase-90
https://cdr.digitellinc.com/p/s/keynote-speaker-nlrp1-inflammasome-involvement-in-cutaneous-responses-to-pollution-95
https://cdr.digitellinc.com/p/s/first-in-human-topical-microbiome-transplantation-with-r-mucosa-for-atopic-dermatitis-100
https://cdr.digitellinc.com/p/s/melaocyte-stem-cells-in-tissue-regeneration-and-introduction-to-paspcr-panamerican-society-for-pigment-cell-research-105
https://cdr.digitellinc.com/p/s/panel-fda-regulatory-updates-for-topical-drug-products-110
https://cdr.digitellinc.com/p/s/combinatorial-treatment-using-an-inhibitor-of-glutamatergic-signaling-troriluzole-and-an-immune-checkpoint-inhibitor-anti-pd-1-resulted-in-a-reduction-of-tumor-growth-and-improved-survival-in-a-sponta-118
https://cdr.digitellinc.com/p/s/pbpk-modeling-of-percutaneous-pharmacokinetics-for-tazarotene-and-tretinoin-creams-applicability-and-challenges-123
https://cdr.digitellinc.com/p/s/using-a-g-protein-coupled-estrogen-receptor-agonist-lns8801-to-treat-grm1-plus-melanoma-in-a-transgenic-mouse-model-127
https://cdr.digitellinc.com/p/s/rheological-and-drug-delivery-evaluation-of-thermosensitive-poloxamer-407-hydrogels-for-administration-of-analgesic-depots-to-chronic-wound-sites-129
https://cdr.digitellinc.com/p/s/use-of-chemical-permeation-enhancers-to-improve-microneedle-transdermal-delivery-of-naltrexone-from-thermosensitive-gels-133
https://cdr.digitellinc.com/p/s/microneedle-assisted-delivery-of-metronidazole-from-hydrogel-vs-cream-preparation-for-a-clinical-study-in-subjects-with-skin-of-color-135
https://cdr.digitellinc.com/p/s/comparative-evaluation-of-kinetics-and-dermal-bioavailability-of-adapalene-from-three-marketed-gel-formulations-using-human-cadaver-skin-140
https://cdr.digitellinc.com/p/s/comparative-evaluation-of-the-transdermal-activity-of-desoximetasone-using-cream-and-ointment-145
https://cdr.digitellinc.com/p/s/efficacy-of-non-proteinogenic-amino-acid-on-dermal-collagen-and-clinical-benefits-150
https://cdr.digitellinc.com/p/s/visualizing-micropore-closure-in-skin-of-color-using-optical-coherence-tomography-154
https://cdr.digitellinc.com/p/s/bioisim-an-ai-driven-pbpk-pd-platform-for-assessment-of-the-drug-skin-retention-following-topical-administration-162
https://cdr.digitellinc.com/p/s/an-insilico-quasi-3d-model-of-transdermal-drug-delivery-for-topical-and-transdermal-applications-184
https://cdr.digitellinc.com/p/s/comparison-of-metronidazole-dermal-pharmacokinetics-between-mini-pig-and-rabbit-189
https://cdr.digitellinc.com/p/s/a-cross-species-retrospective-percutaneous-ivivr-for-topical-dermatological-products-containing-metronidazole-192
https://cdr.digitellinc.com/p/s/cosmetic-formulations-containing-vitamin-c-and-the-instability-challenge-194
https://cdr.digitellinc.com/p/cf/innovations-in-dermatological-sciences-conference-2022-198
https://cdr.digitellinc.com/p/s/conference-welcome-200
https://cdr.digitellinc.com/p/s/understanding-and-manipulating-skin-pigmentation-responses-201
https://cdr.digitellinc.com/p/s/developing-small-peptide-mc1r-selective-agonists-for-sunless-tanning-and-photoprotection-202
https://cdr.digitellinc.com/p/s/mouse-models-for-pigmented-cell-disorders-203
https://cdr.digitellinc.com/p/s/development-of-topical-jak-inhibitors-for-skin-diseases-204
https://cdr.digitellinc.com/p/s/powering-productive-popular-products-by-planning-postulating-predicting-patterning-and-pandering-205
https://cdr.digitellinc.com/p/s/you-think-your-drug-product-is-ready-for-scale-up-and-commercial-launch-think-again-206
https://cdr.digitellinc.com/p/s/digital-technologies-for-topical-formulation-design-207
https://cdr.digitellinc.com/p/s/enhancing-skin-delivery-and-retention-and-reducing-agent-induced-irritation-with-osc-208
https://cdr.digitellinc.com/p/s/challenging-the-norm-innovative-approaches-for-transdermal-delivery-of-lenalidomide-209
https://cdr.digitellinc.com/p/s/closing-for-the-day-210
https://cdr.digitellinc.com/p/s/dermatopharmacokinetics-modelling-assessment-and-optimization-211
https://cdr.digitellinc.com/p/s/why-do-you-need-design-space-to-develop-generic-topical-products-212
https://cdr.digitellinc.com/p/s/rheological-tools-for-the-cosmetic-and-topical-formulator-213
https://cdr.digitellinc.com/p/s/novel-methodologies-to-assess-cutaneous-bioavailability-and-bioequivalence-dermal-microdialysis-and-coherent-raman-imaging-214
https://cdr.digitellinc.com/p/s/update-on-the-human-skin-microbiome-215
https://cdr.digitellinc.com/p/s/triple-biotics-a-prepostbiotic-technology-for-skin-health-216
https://cdr.digitellinc.com/p/s/fda-translating-science-to-regulatory-standards-217
https://cdr.digitellinc.com/p/cf/innovations-in-dermatological-sciences-conference-2022-posters-218
https://cdr.digitellinc.com/p/s/use-of-vibrational-spectroscopy-in-cosmetic-science-and-claims-substantiation-221
https://cdr.digitellinc.com/p/s/overall-conference-evaluation-222
https://cdr.digitellinc.com/p/s/day-1-speaker-evaluations-223
https://cdr.digitellinc.com/p/s/day-2-speaker-evaluations-224
https://cdr.digitellinc.com/p/s/ceramide-liposomes-for-skin-barrier-recovery-a-novel-formulation-based-on-natural-skin-lipids-225
https://cdr.digitellinc.com/p/s/development-and-application-of-a-dermal-pbpk-model-for-an-ethinyl-estradiol-containing-transdermal-delivery-system-to-predict-ethinyl-estradiol-systemic-exposure-following-application-at-different-sit-226
https://cdr.digitellinc.com/p/s/zinc-hyaluronate-a-novel-hyaluronic-acid-complex-227
https://cdr.digitellinc.com/p/s/anti-aging-evaluation-of-bioyouth-tm-egt-ergothioneine-complex-obtained-by-multi-fermentation-228
https://cdr.digitellinc.com/p/s/innovative-screening-and-application-of-lactobacillus-paracasei-with-endogenous-antioxidant-efficacy-229
https://cdr.digitellinc.com/p/s/cordyceps-militaris-ferment-extract-a-novel-anti-aging-active-from-traditional-chinese-medicine-230
https://cdr.digitellinc.com/p/s/rheological-equivalence-testing-according-to-ema-draft-guideline-discussion-of-the-appropriateness-of-the-criteria-based-on-the-comparison-of-generic-and-originator-products-231
https://cdr.digitellinc.com/p/s/development-and-characterization-of-ethosomes-and-transethosomes-loaded-thymoquinone-233
https://cdr.digitellinc.com/p/s/development-and-characterization-of-diclofenac-sodium-loaded-liposomes-235
https://cdr.digitellinc.com/p/s/transdermal-patches-containing-permeation-enhancers-for-topical-delivery-of-actives-236
https://cdr.digitellinc.com/p/s/critical-elements-in-the-development-of-generic-dermatological-products-and-associated-challenges-237
https://cdr.digitellinc.com/p/s/characterization-techniques-for-the-analysis-of-particles-and-globules-in-complex-topical-pharmaceutical-products-238
https://cdr.digitellinc.com/p/s/understanding-the-influence-of-occlusion-on-drug-permeation-from-oxybutynin-transdermal-gel-using-ivpt-239
https://cdr.digitellinc.com/p/s/optical-coherence-tomorgraphy-as-a-noninvasive-tool-to-quantify-collagen-in-skin-240
https://cdr.digitellinc.com/p/s/development-of-liposomal-particles-infused-with-diclofenac-sodium-to-enhance-transdermal-drug-delivery-243
https://cdr.digitellinc.com/p/cf/innovations-in-dermatological-sciences-conference-2023-247
https://cdr.digitellinc.com/p/cf/innovations-in-dermatological-sciences-conference-2023-posters-248
https://cdr.digitellinc.com/p/s/welcomeopening-remarks-249
https://cdr.digitellinc.com/p/s/plenary-the-dermatology-market-whats-hot-and-whats-not-250
https://cdr.digitellinc.com/p/s/pharmaceutical-dermatology-practical-considerations-251
https://cdr.digitellinc.com/p/s/advances-in-antioxidant-technology-for-skin-care-252
https://cdr.digitellinc.com/p/s/break-254
https://cdr.digitellinc.com/p/s/clinical-and-patient-specific-factors-impacting-microneedle-drug-delivery-255
https://cdr.digitellinc.com/p/s/understanding-inci-with-focus-on-the-inci-nomenclature-of-recombinant-proteins-256
https://cdr.digitellinc.com/p/s/overview-of-the-us-cosmetics-regulatory-framework-257
https://cdr.digitellinc.com/p/s/the-multifaceted-roles-played-by-exosomes-in-melanoma-development-and-their-potential-as-therapeutic-agents-258
https://cdr.digitellinc.com/p/s/plenary-percutaneous-absorption-of-sunscreens-and-other-consumer-products-259
https://cdr.digitellinc.com/p/s/us-sunscreen-innovation-are-we-there-yet-260
https://cdr.digitellinc.com/p/s/skin-color-and-skin-of-color-261
https://cdr.digitellinc.com/p/s/foundations-for-people-of-color-the-effect-of-ultramarine-blue-262
https://cdr.digitellinc.com/p/s/break-263
https://cdr.digitellinc.com/p/s/skin-lightening-264
https://cdr.digitellinc.com/p/s/visualization-of-skin-treatment-effects-in-vivo-265
https://cdr.digitellinc.com/p/s/characterization-of-the-biological-activity-of-a-unique-botanical-extract-to-treat-atopic-dermatitis-266
https://cdr.digitellinc.com/p/s/fda-panel-discussion-267
https://cdr.digitellinc.com/p/s/poster-visitation-270
https://cdr.digitellinc.com/p/s/poster-visitation-271
https://cdr.digitellinc.com/p/s/topical-treatments-for-basal-cell-carcinoma-and-actinic-keratosis-in-the-united-states-272
https://cdr.digitellinc.com/p/s/treatment-of-photoaged-skin-with-a-novel-combined-retinol-tripeptide-and-glaucine-containing-cream-clinical-and-histologic-results-from-a-single-center-prospective-clinical-trial-273
https://cdr.digitellinc.com/p/s/sodium-acetylated-hyaluronate-a-novel-approach-for-skin-barrier-repair-and-anti-aging-274
https://cdr.digitellinc.com/p/s/a-novel-endogenous-repair-probiotic-product-based-on-a-double-damage-screening-model-275
https://cdr.digitellinc.com/p/s/influence-of-flaxseed-oil-based-lyotropic-liquid-crystals-on-skin-barrier-function-276
https://cdr.digitellinc.com/p/s/exploration-of-lip-hydration-and-the-impact-of-lipsticks-on-moisture-retention-277
https://cdr.digitellinc.com/p/s/exploring-claims-substantiation-methods-for-nail-care-products-adapting-differential-scanning-calorimetry-dsc-for-comprehensive-assessment-of-nail-properties-and-the-impact-of-cosmetic-treatments-278
https://cdr.digitellinc.com/p/s/development-of-in-vitro-test-methods-for-evaluation-depilatory-products-efficacty-and-their-impact-on-skin-barrier-279
https://cdr.digitellinc.com/p/s/high-external-temperature-significantly-impacts-the-penetration-of-organic-uv-filters-into-human-skin-relevance-for-sunscreen-toxicity-testing-and-climate-change-280
https://cdr.digitellinc.com/p/s/tumor-clearance-of-superficial-basal-cell-carcinoma-treated-with-5-percent-imiquimod-visualized-with-rcm-281
https://cdr.digitellinc.com/p/s/unveiling-the-potential-of-ultra-low-molecular-weight-hyaluronic-acid-for-enhanced-skin-health-282
https://cdr.digitellinc.com/p/s/utility-of-in-vitro-release-testing-ivrt-to-assess-sameness-of-1-percent-clotrimazole-creams-for-use-as-a-biowaiver-283
https://cdr.digitellinc.com/p/s/chitosan-based-hydrogels-for-controlled-delivery-of-asiaticoside-rich-centella-asiatica-extract-284
https://cdr.digitellinc.com/p/s/day-one-speaker-evaluation-286
https://cdr.digitellinc.com/p/s/day-two-speaker-evaluation-287
https://cdr.digitellinc.com/p/s/overall-evaluation-288
https://cdr.digitellinc.com/p/s/mango-seed-kernel-starch-nanoparticles-as-novel-drug-carriers-289
https://cdr.digitellinc.com/p/s/the-effect-of-edge-activator-combinations-using-a-langmuir-technique-in-transethosomal-formulations-for-skin-delivery-of-thymoquinone-292
https://cdr.digitellinc.com/p/cf/innovations-in-dermatological-sciences-conference-2024-293
https://cdr.digitellinc.com/p/s/welcome-294
https://cdr.digitellinc.com/p/s/the-2024-dermatology-market-the-good-the-bad-and-the-ugly-295
https://cdr.digitellinc.com/p/s/non-surgical-skin-cancer-treatment-using-bioadhesive-nanoparticles-296
https://cdr.digitellinc.com/p/s/spotlight-1-fount-bio-297
https://cdr.digitellinc.com/p/s/spotlight-2-sol-gel-298
https://cdr.digitellinc.com/p/s/spotlight-3-naturalis-299
https://cdr.digitellinc.com/p/s/light-based-beauty-tech-the-next-frontier-in-skin-rejuvenation-300
https://cdr.digitellinc.com/p/s/topical-drug-r-and-d-using-open-flow-microperfusion-insights-into-skin-biology-301
https://cdr.digitellinc.com/p/s/spatial-distribution-assessment-of-topically-applied-submicron-drug-precipitants-on-cadaver-human-scalp-302
https://cdr.digitellinc.com/p/s/solving-formulation-challenges-solubility-and-drug-targeting-303
https://cdr.digitellinc.com/p/s/troubleshooting-and-trouble-avoiding-for-topical-semi-solid-formulations-304
https://cdr.digitellinc.com/p/s/ai-image-analytics-for-topicals-implications-for-drug-delivery-and-q3-microstructure-equivalence-305
https://cdr.digitellinc.com/p/s/ground-breaking-digital-transformation-in-topical-product-development-306
https://cdr.digitellinc.com/p/s/fast-fun-excipient-selection-with-formulating-for-efficacy-software-307
https://cdr.digitellinc.com/p/s/pre-formulation-strategies-and-non-clinical-inputs-derisking-clinical-topical-formulation-selection-308
https://cdr.digitellinc.com/p/s/dermal-pk-in-the-clinic-using-streamlined-biopharmaceutics-practices-for-product-evaluation-309
https://cdr.digitellinc.com/p/s/understanding-the-microstructure-of-semi-solid-topical-products-impact-of-manufacturing-and-formulation-parameters-310
https://cdr.digitellinc.com/p/s/bringing-topical-drugs-to-patients-skin-managing-the-drug-delivery-ecosystem-311
https://cdr.digitellinc.com/p/s/introduction-of-a-dermatology-drug-product-to-the-market-and-evolving-post-launch-into-commercialization-an-industry-perspective-312
https://cdr.digitellinc.com/p/cf/innovations-in-dermatological-sciences-conference-2024-posters-314
https://cdr.digitellinc.com/p/s/morning-survey-315
https://cdr.digitellinc.com/p/s/afternoon-survey-316
https://cdr.digitellinc.com/p/s/porous-microneedle-arrays-as-promising-tools-for-the-quantification-of-drugs-in-the-skin-a-proof-of-concept-study-317
https://cdr.digitellinc.com/p/s/topical-and-transdermal-delivery-of-4-phenylbutyric-acid-through-chitosan-nanoparticles-dispersed-in-a-foam-formulation-a-potential-antidote-for-skin-injury-due-to-chemical-warfare-agents-318
https://cdr.digitellinc.com/p/s/radiation-triggers-an-early-fibrotic-response-involving-epithelial-mesenchymal-transition-in-a-human-ex-vivo-skin-model-319
https://cdr.digitellinc.com/p/s/treatment-of-dry-facial-skin-with-a-heparan-sulfate-analog-and-hyaluronic-acid-containing-serum-vs-standard-of-care-results-from-a-split-face-microneedling-clinical-trial-320
https://cdr.digitellinc.com/p/s/evaluating-the-effect-of-iron-oxides-and-ultramarine-blue-on-the-cosmetic-elegance-sun-protective-efficacy-and-stability-of-inorganic-sunscreens-for-dark-skin-321
https://cdr.digitellinc.com/p/s/in-vitro-evaluation-of-topical-and-transdermal-4-phenylbutyric-acid-emulsome-loaded-foam-formulation-for-the-treatment-of-chemical-warfare-agent-induced-skin-injury-322
https://cdr.digitellinc.com/p/s/the-oxytocin-receptor-is-expressed-in-hairy-and-glabrous-skin-near-touch-and-pain-fibers-323
https://cdr.digitellinc.com/p/s/development-of-extrusion-based-3d-printed-hydrophilic-polymeric-transdermal-films-of-pramipexole-dihydrochloride-for-parkinsons-disease-324
https://cdr.digitellinc.com/p/s/impact-of-early-treatment-on-healthcare-utilization-for-psoriasis-and-psoriatic-arthritis-and-the-emergence-of-osteoarthritis-in-psoriasis-patients-325
https://cdr.digitellinc.com/p/s/exploring-turmeric-and-associated-curcuminoids-in-the-treatment-of-vitiligo-326
https://cdr.digitellinc.com/p/s/assessing-treatment-of-scalp-conditions-in-ethnically-diverse-adult-populations-a-survey-based-study-328
https://cdr.digitellinc.com/p/s/topical-administration-of-adapalene-gels-bioequivalence-pharmacokinetics-pharmacological-responses-and-pbpk-modeling-329
https://cdr.digitellinc.com/p/s/caffeinecafestol-loaded-liposomes-with-improved-delivery-of-actives-to-the-dermal-layer-of-the-skin-in-vitro-330
https://cdr.digitellinc.com/p/s/welcome-dean-joseph-barone-331
https://cdr.digitellinc.com/p/s/utility-of-model-based-approaches-in-accelerating-market-entry-of-topical-generic-products-332
https://cdr.digitellinc.com/p/s/formulate-faster-with-zoomlab-333
https://cdr.digitellinc.com/p/s/formulating-topical-semisolids-with-self-emulsifying-systems-334
https://cdr.digitellinc.com/p/s/kenvue-research-novel-moisturizing-factor-335
https://cdr.digitellinc.com/p/s/lunch-336
https://cdr.digitellinc.com/p/s/rheology-tips-for-generic-pharmaceuticals-337
https://cdr.digitellinc.com/p/s/introduction-to-in-vitro-release-testing-ivrt-338
https://cdr.digitellinc.com/p/s/rades-company-presentation-no-audio-339
https://cdr.digitellinc.com/p/s/coating-and-dryer-logan-instrument-340
https://cdr.digitellinc.com/p/s/diffusion-cell-apparatus-with-automated-sampling-logan-instrument-341
https://cdr.digitellinc.com/p/s/usp-4-apparatus-open-loop-logan-instrument-342
https://cdr.digitellinc.com/p/s/usp-4-apparatus-close-loop-logan-instrument-343
https://cdr.digitellinc.com/p/s/automated-apparatus-3-and-7-logan-instrument-344
https://cdr.digitellinc.com/p/s/sponsor-of-the-year-award-345
https://cdr.digitellinc.com/p/s/rutgers-research-dr-michael-zwick-346